Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis
Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic
Document type Journal Article
PubMed
36900201
PubMed Central
PMC10000228
DOI
10.3390/cancers15051409
PII: cancers15051409
Knihovny.cz E-resources
- Keywords
- RNU, UTUC, surgical approach, transitional cell carcinoma, treatment outcomes,
- Publication type
- Journal Article MeSH
OBJECTIVES: To identify correlates of survival and perioperative outcomes of upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), and robotic (RRNU) radical nephroureterectomy (RNU). METHODS: We conducted a retrospective, multicenter study that included non-metastatic UTUC patients who underwent RNU between 1990-2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment and were adjusted by 1:1:1 propensity score matching (PSM). Survival outcomes per group were estimated for recurrence-free survival (RFS), bladder recurrence-free survival (BRFS), cancer-specific survival (CSS), and overall survival (OS). Perioperative outcomes: Intraoperative blood loss, hospital length of stay (LOS), and overall (OPC) and major postoperative complications (MPCs; defined as Clavien-Dindo > 3) were assessed between groups. RESULTS: Of the 2434 patients included, 756 remained after PSM with 252 in each group. The three groups had similar baseline clinicopathological characteristics. The median follow-up was 32 months. Kaplan-Meier and log-rank tests demonstrated similar RFS, CSS, and OS between groups. BRFS was found to be superior with ORNU. Using multivariable regression analyses, LRNU and RRNU were independently associated with worse BRFS (HR 1.66, 95% CI 1.22-2.28, p = 0.001 and HR 1.73, 95%CI 1.22-2.47, p = 0.002, respectively). LRNU and RRNU were associated with a significantly shorter LOS (beta -1.1, 95% CI -2.2-0.02, p = 0.047 and beta -6.1, 95% CI -7.2-5.0, p < 0.001, respectively) and fewer MPCs (OR 0.5, 95% CI 0.31-0.79, p = 0.003 and OR 0.27, 95% CI 0.16-0.46, p < 0.001, respectively). CONCLUSIONS: In this large international cohort, we demonstrated similar RFS, CSS, and OS among ORNU, LRNU, and RRNU. However, LRNU and RRNU were associated with significantly worse BRFS, but a shorter LOS and fewer MPCs.
Department of Urology 2nd Faculty of Medicine Charles University 150 06 Prague Czech Republic
Department of Urology Comprehensive Cancer Center Medical University of Vienna 1090 Vienna Austria
Department of Urology Icahn School of Medicine at Mount Sinai New York NY 10029 USA
Department of Urology Kindai University Faculty of Medicine Osaka 589 8511 Japan
Department of Urology Lions Gate Hospital North Vancouver BC V7L 2L7 Canada
Department of Urology Luzerner Kantonsspital 6004 Lucerne Switzerland
Department of Urology Mayo Clinic Rochester MN 55902 USA
Department of Urology Medical University of Silesia 40 752 Katowice Poland
Department of Urology Penn State Health Hershey PA 17033 USA
Department of Urology St Marianna University School of Medicine Kawasaki 214 8525 Japan
Department of Urology University Hospital Zurich 8091 Zurich Switzerland
Department of Urology University Medical Center Hamburg Eppendorf 20251 Hamburg Germany
Department of Urology University of Florence Careggi Hospital 50100 Florence Italy
Department of Urology University of Rennes 35000 Rennes France
Department of Urology University of Texas Southwestern Dallas TX 75390 USA
Department of Urology UROSUD La Croix Du Sud Hospital 31130 Quint Fonsegrives France
Department of Urology Weill Cornell Medical College New York NY 10065 USA
Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman 19328 Jordan
Institute for Urology and Reproductive Health Sechenov University 119991 Moscow Russia
Karl Landsteiner Institute of Urology and Andrology 1090 Vienna Austria
Urology Department Fundació Puigvert Autonomous University of Barcelona 08025 Barcelona Spain
Vattikuti Urology Institute Henry Ford Hospital Detroit MI 48202 USA
See more in PubMed
Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2021. CA Cancer J. Clin. 2021;71:7–33. doi: 10.3322/caac.21654. PubMed DOI
Margulis V., Shariat S.F., Matin S.F., Kamat A.M., Zigeuner R., Kikuchi E., Lotan Y., Weizer A., Raman J., Wood C.G., et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–1233. doi: 10.1002/cncr.24135. PubMed DOI
Rouprêt M., Babjuk M., Burger M., Capoun O., Cohen D., Compérat E.M., Cowan N.C., Dominguez-Escrig J.L., Gontero P., Mostafid A.H., et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur. Urol. 2021;79:62–79. doi: 10.1016/j.eururo.2020.05.042. PubMed DOI
Tinay I., Gelpi-Hammerschmidt F., Leow J.J., Allard C.B., Rodriguez D., Wang Y., Chung B.I., Chang S.L. Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: A 10-year population-based analysis. BJU Int. 2016;117:954–960. doi: 10.1111/bju.13375. PubMed DOI
Mourmouris P., Argun O.B., Tzelves L., Tuna M.B., Gourtzelidou M., Tziotis A., Kural A.R., Skolarikos A. Is robotic radical nephroureterectomy a safe alternative to open approach: The first prospective analysis. Arch. Ital. Urol. Androl. 2021;93:408–411. doi: 10.4081/aiua.2021.4.408. PubMed DOI
Simone G., Papalia R., Guaglianone S., Ferriero M., Leonardo C., Forastiere E., Gallucci M. Laparoscopic versus Open Nephroureterectomy: Perioperative and Oncologic Outcomes from a Randomised Prospective Study. Eur. Urol. 2009;56:520–526. doi: 10.1016/j.eururo.2009.06.013. PubMed DOI
Stewart G.D., Humphries K.J., Cutress M.L., Riddick A.C., McNeill S.A., Tolley D.A. Long-Term Comparative Outcomes of Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial-Cell Carcinoma After a Median Follow-Up of 13 Years. J. Endourol. 2011;25:1329–1335. doi: 10.1089/end.2011.0223. PubMed DOI
Lee H., Kim H.J., Lee S.E., Hong S.K., Byun S.-S. Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma. PLoS ONE. 2019;14:e0210401. doi: 10.1371/journal.pone.0210401. PubMed DOI PMC
Morselli S., Vitelli F.D., Verrini G., Sebastianelli A., Campi R., Liaci A., Spatafora P., Barzaghi P., Ferrari G., Gacci M., et al. Comparison of Tumor Seeding and Recurrence Rate After Laparoscopic vs. Open Nephroureterectomy for Upper Urinary Tract Transitional Cell Carcinoma. Front. Surg. 2021;8:652. doi: 10.3389/fsurg.2021.769527. PubMed DOI PMC
Zeuschner P., Vollmer S.G., Linxweiler J., Wagenpfeil G., Wagenpfeil S., Saar M., Siemer S., Stöckle M., Heinzelbecker J. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years. Surg. Oncol. 2021;38:101607. doi: 10.1016/j.suronc.2021.101607. PubMed DOI
Hanna N., Sun M., Trinh Q.-D., Hansen J., Bianchi M., Montorsi F., Shariat S.F., Graefen M., Perrotte P., Karakiewicz P.I. Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series. Eur. Urol. 2012;61:715–721. doi: 10.1016/j.eururo.2011.12.026. PubMed DOI
Pearce S.M., Pariser J.J., Patel S.G., Steinberg G.D., Shalhav A.L., Smith N.D. The effect of surgical approach on performance of lymphadenectomy and perioperative morbidity for radical nephroureterectomy. Urol. Oncol. Semin. Orig. Investig. 2016;34:121.e15–121.e21. doi: 10.1016/j.urolonc.2015.09.008. PubMed DOI
Rodriguez J.F., Packiam V.T., Boysen W.R., Johnson S.C., Smith Z.L., Smith N.D., Shalhav A.L., Steinberg G.D. Utilization and Outcomes of Nephroureter-ectomy for Upper Tract Urothelial Carcinoma by Surgical Approach. J. Endourol. 2017;31:661–665. doi: 10.1089/end.2017.0086. PubMed DOI
Mullen E., Ahmed K., Challacombe B. Systematic review of open versus laparoscopic versus robot-assisted nephroureterectomy. Rev. Urol. 2017;19:32–43. PubMed PMC
Peyronnet B., Seisen T., Dominguez-Escrig J.L., Bruins H.M., Yuan C.Y., Lam T., Maclennan S., N’dow J., Babjuk M., Comperat E., et al. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Asso-ciation of Urology Guidelines Systematic Review. Eur. Urol. Focus. 2019;5:205–223. doi: 10.1016/j.euf.2017.10.003. PubMed DOI
Veccia A., Antonelli A., Francavilla S., Simeone C., Guruli G., Zargar H., Perdoná S., Ferro M., Carrieri G., Hampton L.J., et al. Robotic versus other nephroureterectomy tech-niques: A systematic review and meta-analysis of over 87,000 cases. World J. Urol. 2020;38:845–852. doi: 10.1007/s00345-019-03020-1. PubMed DOI
Piszczek R., Nowak Ł., Krajewski W., Chorbińska J., Poletajew S., Moschini M., Kaliszewski K., Zdrojowy R. Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: An updated meta-analysis. World J. Surg. Oncol. 2021;19:129. doi: 10.1186/s12957-021-02236-z. PubMed DOI PMC
Lughezzani G., Jeldres C., Isbarn H., Sun M., Shariat S.F., Alasker A., Pharand D., Widmer H., Arjane P., Graefen M., et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients. Eur. J. Cancer. 2009;45:3291–3297. doi: 10.1016/j.ejca.2009.06.016. PubMed DOI
Favaretto R.L., Shariat S.F., Chade D.C., Godoy G., Adamy A., Kaag M., Bochner B.H., Coleman J., Dalbagni G. The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur. Urol. 2010;58:574–580. doi: 10.1016/j.eururo.2010.07.003. PubMed DOI PMC
Xylinas E., Rink M., Cha E., Clozel T., Lee R.K., Fajkovic H., Comploj E., Novara G., Margulis V., Raman J., et al. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur. Urol. 2014;65:210–217. doi: 10.1016/j.eururo.2012.04.052. PubMed DOI
Roscigno M., Brausi M., Heidenreich A., Lotan Y., Margulis V., Shariat S.F., Van Poppel H., Zigeuner R. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer. Eur. Urol. 2011;60:776–783. doi: 10.1016/j.eururo.2011.07.009. PubMed DOI
Rink M., Fajkovic H., Cha E.K., Gupta A., Karakiewicz P.I., Chun F.K., Lotan Y., Shariat S.F. Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma. Eur. Urol. 2012;61:854–855. doi: 10.1016/j.eururo.2011.12.055. PubMed DOI
White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: Issues and guidance for practice. Stat. Med. 2011;30:377–399. doi: 10.1002/sim.4067. PubMed DOI
van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat. Methods Med. Res. 2007;16:219–242. doi: 10.1177/0962280206074463. PubMed DOI
Brookhart M.A., Schneeweiss S., Rothman K., Glynn R.J., Avorn J., Stürmer T. Variable Selection for Propensity Score Models. Am. J. Epidemiol. 2006;163:1149–1156. doi: 10.1093/aje/kwj149. PubMed DOI PMC
Clements M.B., Krupski T.L., Culp S.H. Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis. Ann. Surg. Oncol. 2018;25:2550–2562. doi: 10.1245/s10434-018-6557-8. PubMed DOI
Kim S.H., Song M.K., Kim J.K., Hong B., Kang S.H., Ku J.H., Jeong B.C., Seo H.K., On behalf of Urothelial Cancer-Advanced Research and Treatment (UCART) Study Group Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis. Cancer Res. Treat. 2019;51:963–972. PubMed PMC
Moschini M., Zamboni S., Afferi L., Pradere B., Abufaraj M., Soria F., D’Andrea D., Roupret M., De la Taille A., Simeone C., et al. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis. Arab. J. Urol. 2020;19:31–36. doi: 10.1080/2090598X.2020.1817720. PubMed DOI PMC
Xylinas E., Colin P., Audenet F., Phe V., Cormier L., Cussenot O., Houlgatte A., Karsenty G., Bruyère F., Polguer T., et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: Predictors and impact on subsequent oncological outcomes from a national multicenter study. World J. Urol. 2012;31:61–68. doi: 10.1007/s00345-012-0957-3. PubMed DOI
Xylinas E., Kluth L., Passoni N., Trinh Q.-D., Rieken M., Lee R.K., Fajkovic H., Novara G., Margulis V., Raman J.D., et al. Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool. Eur. Urol. 2013;65:650–658. doi: 10.1016/j.eururo.2013.09.003. PubMed DOI
Shigeta K., Kikuchi E., Hagiwara M., Ando T., Mizuno R., Miyajima A., Nakagawa K., Oya M. Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma. Surg. Oncol. 2017;26:73–79. doi: 10.1016/j.suronc.2017.01.003. PubMed DOI
Chen M.-K., Ye Y.-L., Zhou F.-J., Liu J.-Y., Lu K.-S., Han H., Liu Z.-W., Xu Z.-Z., Qin Z.-K. Clipping the extremity of ureter prior to nephroureterectomy is effective in preventing subsequent bladder recurrence after upper urinary tract urothelial carcinoma. Chin. Med. J. 2012;125:3821–3826. PubMed
Pizzighella M., Bruyère F., Peyronnet B., Graffeille V., Brichart N., Mori K., Verhoest G., Bensalah K., Moschini M., Xylinas E., et al. The Management of Distal Ureter During Radical Nephroureterectomy Does Not Influence Bladder Recurrence. J. Endourol. 2022;36:77–82. doi: 10.1089/end.2021.0303. PubMed DOI
Lai S., Guo R., Seery S., Wu P., Liu J., Zhang Y., Zhu S., Li X., Liu M., Wang J. Assessing the impact of different distal ureter management techniques during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma on oncological outcomes: A systematic re-view and meta-analysis. Int. J. Surg. 2020;75:165–173. doi: 10.1016/j.ijsu.2020.01.016. PubMed DOI
Lai S.-C., Wu P.-J., Liu J.-Y., Seery S., Liu S.-J., Long X.-B., Liu M., Wang J.-Y. Oncological impact of different distal ureter managements during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma. World J. Clin. Cases. 2020;8:5104–5115. doi: 10.12998/wjcc.v8.i21.5104. PubMed DOI PMC
O’Brien T., Ray E., Singh R., Coker B., Beard R. Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial) Eur. Urol. 2011;60:703–710. doi: 10.1016/j.eururo.2011.05.064. PubMed DOI
Nazzani S., Bazinet A., Preisser F., Mazzone E., Tian Z., Mistretta F., Shariat S., Saad F., Zorn K.C., Montanari E., et al. Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis. Int. J. Urol. 2019;26:487–492. doi: 10.1111/iju.13916. PubMed DOI